Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Topical netarsudil for the treatment of primary corneal endothelial degeneration in dogs

Scientific Reports(2024)10.1038/s41598-024-56084-4Source: DataRank Database

Topical netarsudil for the treatment of primary corneal endothelial degeneration in dogs is a research paper published in Scientific Reports (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 0.52)OA: goldTopics (74)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Sangwan Park ORCID,Melaney A. Mayes,Karolina Roszak,Michelle Ferneding,Nayeli Echeverria

Live enrichment

PubMed:38485975 PMC:PMC10940293 OpenAlex:https://openalex.org/W4392792938

National Institutes of Health

Grant: K08EY028199

National Institutes of Health

Grant: R01EY016134

American Kennel Club Canine Health Foundation

Grant: 02696

NEI NIH HHS

Grant: P30 EY012576

NEI NIH HHS

Grant: R01 EY033733

NIGMS NIH HHS

Grant: T32 GM135741

National Institutes of Health

Grant: 1K11EY000325-01

ENDOGENOUS INHIBITION OF OCULAR ANGIOGENESIS

National Institutes of Health

Grant: 5P30EY012576-18

Vision Research Core Grant

National Institutes of Health

Grant: 5R01EY016134-08

Modulation of Signal Transduction by Nano-Topography

National Institutes of Health

Grant: 5K08EY028199-05

Modulation of Hsp90 signaling to limit corneal fibrosis and improve ocular drug penetration

National Institutes of Health

Grant: 3R01EY033733-02S1

Advancing novel therapies for optic neuropathy with a nonhuman primate model

Center for Companion Animal Health, University of California, Davis

FWCI

0.52

Citation Percentile

0.6%

Citation Trend

2024

goldLicense: cc-by

journalhttps://www.nature.com/articles/s41598-024-56084-4.pdf

publisherhttps://www.nature.com/articles/s41598-024-56084-4.pdf

publisherhttps://www.nature.com/articles/s41598-024-56084-4

journalhttps://doi.org/10.1038/s41598-024-56084-4

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38485975

Fields of Study

Corneal Surgery and TreatmentsGlaucoma and retinal disordersCorneal surgery and disorders0403 veterinary science03 medical and health sciences0302 clinical medicine04 agricultural and veterinary sciencesAnimalsDogsBenzoatesbeta-AlanineCorneal Dystrophies, HereditaryCorneal EdemaDisease ProgressionIsoquinolinesOphthalmic SolutionsProspective StudiesSulfonamides

MeSH Terms

AnimalsBenzoatesCorneal Dystrophies, HereditaryDogsHumansIsoquinolinesOphthalmic SolutionsProspective StudiesSulfonamidesbeta-AlanineCorneal EdemaDisease Progression

Keywords

Primary (astronomy)Degeneration (medical)MedicineOphthalmologyPhysicsDogs (mesh)Corneal DystrophiesIsoquinolines (mesh)ScienceDisease Progression (mesh)610EyeEye Disease and Disorders of Vision (rcdc)BenzoatesArticle3212 Ophthalmology and Optometry (for-2020)Eye (hrcs-hc)DogsCorneal Edema (mesh)Animals (mesh)AnimalsHereditary (mesh)Prospective StudiesProspective Studies (mesh)32 Biomedical and Clinical Sciences (for-2020)Eye Disease and Disorders of VisionOphthalmology and OptometryCorneal Dystrophies, HereditarySulfonamides6.1 Pharmaceuticals (hrcs-rac)Biomedical and Clinical SciencesQCorneal EdemaRBenzoates (mesh)IsoquinolinesHereditaryOphthalmic Solutions (mesh)6.1 Pharmaceuticalsbeta-AlanineDisease Progressionbeta-Alanine (mesh)Ophthalmic SolutionsSulfonamides (mesh)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being